Home/Pipeline/Verkazia® (ciclosporin)

Verkazia® (ciclosporin)

Vernal Keratoconjunctivitis

ApprovedCommercial

Key Facts

Indication
Vernal Keratoconjunctivitis
Phase
Approved
Status
Commercial
Company

About Santen Pharmaceutical

Santen Pharmaceutical is a leading global player in the ophthalmology market, dedicated to addressing unmet medical needs in eye diseases. The company leverages its deep expertise in ocular drug delivery and formulation to build a diversified portfolio spanning glaucoma, retinal diseases, dry eye, and inflammation. With a long history of innovation and a commitment to research, Santen aims to contribute to the well-being of patients worldwide through its specialized ophthalmic solutions.

View full company profile

Other Vernal Keratoconjunctivitis Drugs

DrugCompanyPhase
SCD-044SPARCPhase 3